Mexico Health Review is your entrance into the ranks of the elite of Mexico’s health industry. Take advantage of this opportunity to get inside the minds of the leaders who are shaping Mexico’s health industry, including public sector decision-makers, domestic and international C-level executives, top regulators, key voices in the pharmaceutical and biotech segments and equipment suppliers and services providers. Mexico’s health community at your fingertips.
HOW WE DO IT:
Cutting-edge information based on more than 180 interviews with the most influential business leaders in the Mexican health industry, the country’s political leaders and key policymakers
Dedicated editorial team with experience covering Mexico’s health industry and in-depth understanding of global trends, technological advances and international best practices
Uniquely customized readership that ensures unprecedented reach among key decision-makers in Mexico and around the world
STRAINED BY BUDGET CUTS, HEALTH SECTOR LOOKS FOR CHANGE UNDER AMLO
The Mexican healthcare sector faced several challenges in 2018. Budget cuts have limited public sector maneuverability and uncertainty has made many investors cautious in the short-term. While the hurdles have been significant, the Mexican economy remains steady and the local market for pharmaceuticals and medical devices shows no sign of slowing down. With a new administration headed by President-elect Andrés Manuel López Obrador ready to enter office, universal healthcare is at the top of the agenda, along with the need to address the rise in chronic diseases and their management, while adapting regulations to the rapidly changing requirements of a burgeoning technological environment.
Among the industry’s buzzwords at this time of change are Big Data, automation and innovation. As Industry 4.0 practices penetrate the health sector one key hurdle stands in the way: Mexico’s fragmented system makes it difficult to share data and realize the integration of information that characterizes the technological revolution now under way.
Healthcare will always be essential not only for individuals, but also for the country’s economic growth, and as the industry opens further to private investment, the opportunities are many. Both old and new companies are entering or expanding in the market, attracted by the country’s large population and its changing epidemiological profile, which will only increase the need for new healthcare services. Moreover, many are investing in innovative solutions or technologies to better identify existing challenges and develop comprehensive strategies to solve them while optimizing resources and keeping bottom lines in the black.